Indo Us Biotech peers

Companies like Indo Us Biotechlatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

INDOUS₹78.36

Indo Us Biotech Limited

· FMCG & Retail
₹ CrorePeersKOHINOORNATHBIOGENAGRITECHSARVESHWARSUKHJITSREGAALBSHSLGULPOLYMcap ₹157 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
INDOUS
FY26
KOHINOOR
FY26
NATHBIOGEN
FY26
AGRITECH
FY21
Peer
Average
Valuation — at last close
P/E11.98×◆ 1.24×6.31×—3.78× +217%
P/B1.70×—◆ 0.37×—0.37× +359%
EV/EBITDA11.05×◆ -37.93×5.99×—-15.97× +169%
Market Cap₹157 Cr₹100 Cr₹252 Cr₹47.9 Cr₹133 Cr +18%
Growth
Revenue CAGR 3Y—◆ 21.38%13.88%—17.63%
Revenue CAGR 5Y—-11.09%——-11.09%
Net Income CAGR 3Y——5.93%—5.93%
Revenue YoY (latest Q)-51.22%81.82%15.76%◆ 265.22%120.93% -142%
Net Income YoY (latest Q)-206.35%◆ 202.44%-13.46%0.53%63.17% -427%
Profitability
EBITDA Margin◆ 15.40%-4.41%11.78%-195.75%-62.79% +125%
Net Income Margin11.88%◆ 54.65%9.35%-1542.98%-492.99% +102%
Return on Common Equity◆ 15.34%-62.67%6.28%—-28.20% +154%
Return on Capital Employed18.40%◆ 31.77%7.11%—19.44% -5%
Return on Assets11.36%◆ 53.53%3.92%—28.73% -60%
Credit & Quality
Total Debt/Equity0.40×◆ -1.57×0.20×—-0.69× +158%
Interest Coverage◆ 7.18×-2.01×3.03×-0.56×0.15× +4583%
Scale — latest FY
Revenue / Total Income₹110 Cr₹148 Cr₹445 Cr₹0.2 Cr₹198 Cr -44%
Net Income₹13.1 Cr₹80.7 Cr₹41.6 Cr−₹3 Cr₹39.8 Cr -67%
Total Assets₹133 Cr₹92 Cr₹1,097 Cr—₹595 Cr -78%
EPS₹6.54₹21.75₹20.98₹-5.01₹12.57 -48%
Book Value per Share₹46.15₹-25.32₹358.06—₹166.37 -72%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.